Proton pump inhibitors (PPIs) have several limitations to their efficacy including insufficient acid suppression. slow onset of action. and variable efficacy among patients due to CYP2C19 metabolism. Potassium-competitive acid blockers inhibit H+-K+-ATPase in a reversible and K+-competitive manner. https://globechemicalcompanyls.shop/product-category/facial-tissue/